Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry.

Marí-Alfonso B, Simeón-Aznar CP, Guillén-Del Castillo A, Rubio-Rivas M, Trapiella-Martínez L, Todolí-Parra JA, Rodríguez Carballeira M, Marín-Ballvé A, Iniesta-Arandia N, Colunga-Argüelles D, Castillo-Palma MJ, Sáez-Comet L, Egurbide-Arberas MV, Ortego-Centeno N, Freire M, Vargas Hitos JA, Chamorro AJ, Madroñero-Vuelta AB, Perales-Fraile I, Pla-Salas X, Fernández-De-La-Puebla RA, Fonollosa-Pla V, Tolosa-Vilella C; RESCLE Investigators; Systemic Autoimmune Diseases Study Group (GEAS).

Semin Arthritis Rheum. 2018 Jun;47(6):849-857. doi: 10.1016/j.semarthrit.2017.10.004. Epub 2017 Oct 6.

PMID:
29246416
2.

Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.

Iniesta Arandia N, Simeón-Aznar CP, Guillén Del Castillo A, Colunga Argüelles D, Rubio-Rivas M, Trapiella Martínez L, García Hernández FJ, Sáez Comet L, Egurbide Arberas MV, Ortego-Centeno N, Freire M, Marí Alfonso B, Vargas Hitos JA, Ríos Blanco JJ, Todolí Parra JA, Rodríguez-Carballeira M, Marín Ballvé A, Chamorro Fernández AJ, Pla Salas X, Madroñero Vuelta AB, Ruiz Muñoz M, Fonollosa Pla V, Espinosa G; RESCLE investigators, Autoimmune Diseases Study Group (GEAS).

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):98-105. Epub 2017 Sep 21.

3.

Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE).

Rubio-Rivas M, Simeón-Aznar CP, Velasco C, Marí-Alfonso B, Espinosa G, Corbella X, Colunga-Argüelles D, Egurbide-Arberas MV, Ortego-Centeno N, Vargas-Hitos JA, Freire M, Ríos-Blanco JJ, Trapiella-Martínez L, Rodríguez-Carballeira M, Fonollosa-Pla V; RESCLE investigators, Autoimmune Diseases Study Group (GEAS).

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):40-47. Epub 2017 Feb 6.

PMID:
28229826
4.

Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.

Tolosa-Vilella C, Morera-Morales ML, Simeón-Aznar CP, Marí-Alfonso B, Colunga-Arguelles D, Callejas Rubio JL, Rubio-Rivas M, Freire-Dapena M, Guillén-Del Castillo A, Iniesta-Arandia N, Castillo-Palma MJ, Egurbide-Arberas M, Trapiellla-Martínez L, Vargas-Hitos JA, Todolí-Parra JA, Rodriguez-Carballeira M, Marin-Ballvé A, Pla-Salas X, Rios-Blanco JJ, Fonollosa-Pla V; RESCLE Investigators, Autoimmune Diseases Study Group (GEAS).

Semin Arthritis Rheum. 2016 Oct;46(2):200-8. doi: 10.1016/j.semarthrit.2016.04.007. Epub 2016 May 18.

PMID:
27312381
5.

[Prognostic implications of extra-hepatic clinical manifestations, autoimmunity and microscopic nail capillaroscopy in patients with primary biliary cirrhosis].

Marí-Alfonso B, Amengual-Guedan MJ, Vergara-Gómez M, Simeón-Aznar CP, Fonollosa-Plà V, Jove-Buxeda E, Oliva-Morera J, Tolosa-Vilella C.

Med Clin (Barc). 2016 Jan 1;146(1):8-15. doi: 10.1016/j.medcli.2015.02.026. Epub 2015 May 12. Spanish.

PMID:
25978920
6.

Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis.

Márquez A, Solans R, Hernández-Rodríguez J, Cid MC, Castañeda S, Ramentol M, Morado IC, Rodriguez-Rodriguez L, Narváez J, Gómez-Vaquero C, Miranda-Filloy JA, Martínez-Taboada VM, Ríos R, Sopeña B, Monfort J, García-Villanueva MJ, Martínez-Zapico A, Marí-Alfonso B, Sánchez-Martín J, Unzurrunzaga A, Raya E, de Miguel E, Hidalgo-Conde A, Blanco R, González-Gay MÁ, Martín J; Spanish GCA Consortium.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S30-3. Epub 2014 Apr 7.

PMID:
24709033
7.

Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.

Serrano A, Márquez A, Mackie SL, Carmona FD, Solans R, Miranda-Filloy JA, Hernández-Rodríguez J, Cid MC, Castañeda S, Morado IC, Narváez J, Blanco R, Sopeña B, García-Villanueva MJ, Monfort J, Ortego-Centeno N, Unzurrunzaga A, Marí-Alfonso B, Sánchez Martín J, de Miguel E, Magro C, Raya E; UK GCA Consortium; Spanish GCA Consortium, Braun N, Latus J, Molberg O, Lie BA, Moosig F, Witte T, Morgan AW, González-Gay MA, Martín J.

Ann Rheum Dis. 2013 Nov;72(11):1882-1886. doi: 10.1136/annrheumdis-2013-203641. Epub 2013 Aug 14.

8.

A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis.

Serrano A, Carmona FD, Castañeda S, Miranda-Filloy JA, Morado IC, Gomez-Vaquero C, Solans R, Sopeña B, Blanco R, Unzurrunzaga A, Ortego-Centeno N, Marí-Alfonso B, Hidalgo-Conde A, Hernández-Rodríguez J, Cid MC, Martín J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S5-8. Epub 2013 Jan 7.

PMID:
23306142
9.

Evidence of association of the NLRP1 gene with giant cell arteritis.

Serrano A, Carmona FD, Castañeda S, Solans R, Hernández-Rodríguez J, Cid MC, Prieto-González S, Miranda-Filloy JA, Rodríguez-Rodríguez L, Morado IC, Gomez-Vaquero C, Blanco R, Sopeña B, Ortego-Centeno N, Unzurrunzaga A, Marí-Alfonso B, Sánchez-Martín J, García-Villanueva MJ, Hidalgo-Conde A, Pazzola G, Boiardi L, Salvarani C, González-Gay MA, Martín J.

Ann Rheum Dis. 2013 Apr;72(4):628-30. doi: 10.1136/annrheumdis-2012-202609. Epub 2012 Dec 19. No abstract available.

10.

Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population.

Serrano A, Carmona FD, Miranda-Filloy JA, Castañeda S, Rodríguez-Rodríguez L, Morado IC, Gómez-Vaquero C, Solans R, Sopeña B, Blanco R, Unzurrunzaga A, Ortego-Centeno N, Marí-Alfonso B, de Miguel E, Hidalgo-Conde A, Martín J, González-Gay MA.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S29-33. Epub 2012 May 10.

PMID:
22512842
11.

Infliximab for life-threatening pulmonary artery aneurysms in Behçet's disease. A case report.

Tolosa-Vilella C, Capela CA, Monteagudo-Jiménez M, Marí-Alfonso B.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S94-5. Epub 2011 Sep 27. No abstract available.

PMID:
21385550
12.

A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis.

Carmona FD, Serrano A, Rodríguez-Rodríguez L, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Solans R, Sopeña B, Marí-Alfonso B, Unzurrunzaga A, Ortego-Centeno N, Blanco R, de Miguel E, Hidalgo-Conde A, Martín J, González-Gay MA.

J Rheumatol. 2011 Dec;38(12):2598-601. doi: 10.3899/jrheum.110685. Epub 2011 Oct 1.

PMID:
21965647
13.

Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis.

Carmona FD, Rodríguez-Rodríguez L, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Marí-Alfonso B, Unzurrunzaga A, Ríos-Fernández R, Blanco R, de Miguel E, Martín J, González-Gay MA.

Hum Immunol. 2011 May;72(5):458-61. doi: 10.1016/j.humimm.2011.02.009. Epub 2011 Feb 25.

PMID:
21354457
14.

Role of rs1343151 IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Carmona FD, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Marí-Alfonso B, Gómez-Vaquero C, Amigo-Díaz E, Ríos-Fernández R, Blanco R, Llorca J, Fernández-Gutiérrez B, Martín J, González-Gay MA.

J Rheumatol. 2011 May;38(5):889-92. doi: 10.3899/jrheum.101046. Epub 2011 Feb 1.

PMID:
21285166
15.

Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Gómez-Vaquero C, Marí-Alfonso B, Miranda-Filloy JA, Narvaez J, Ortego-Centeno N, Vicente EF, Blanco R, Amigo-Diaz E, Fernández-Gutiérrez B, Martin J, González-Gay MA.

Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S12-6. Epub 2011 May 11.

PMID:
21269573
16.

Influence of IL2RA rs2104286 polymorphism in the risk of biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Marí-Alfonso B, Gómez-Vaquero C, Miranda-Filloy JA, Ortego-Centeno N, Narvaez J, Blanco R, Fernández-Gutiérrez B, Martín J, González-Gay MA.

J Rheumatol. 2010 Nov;37(11):2331-3. doi: 10.3899/jrheum.100388. Epub 2010 Sep 1.

PMID:
20810507
17.

Influence of CD40 rs1883832 polymorphism in susceptibility to and clinical manifestations of biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Marí-Alfonso B, Gómez-Vaquero C, Miranda-Filloy JA, Narvaez J, Ortego-Centeno N, Blanco R, Fernández-Gutiérrez B, Martín J, González-Gay MA.

J Rheumatol. 2010 Oct;37(10):2076-80. doi: 10.3899/jrheum.100362. Epub 2010 Aug 3.

PMID:
20682661
18.

[Analysis of a series of 55 patients with biopsy proven giant cell temporal arteritis].

Bustamante Maldonado E, Marí Alfonso B, Monteagudo Jiménez M, Casanovas Martínez A, Jordana Comajuncosa R, Tolosa Vilella C, Oristrell Salvá J.

An Med Interna. 2004 Oct;21(10):473-6. Spanish.

PMID:
15511196
19.

Olanzapine-induced agranulocytosis: a case report and review of the literature.

Tolosa-Vilella C, Ruiz-Ripoll A, Mari-Alfonso B, Naval-Sendra E.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Feb;26(2):411-4. Review.

PMID:
11817522

Supplemental Content

Loading ...
Support Center